Pharmacy Week in Review: October 6, 2017

Most Popular

Related Articles

Top news of the week from Specialty Pharmacy Times.
A new, inexpensive diagnostic test can help identify patients who require immediate treatment for hepatitis B virus across Africa.
Immunotherapy is established as an effective treatment for numerous types of cancer and has emerged as a fourth pillar of cancer care, in addition to surgery, cytotoxic therapy, and radiotherapy. Given the rapid expansion of indications for immunotherapy agents and combination therapies, oncology pharmacists must take on a larger role to ensure patients understand their treatment regimens. This activity will provide information on available immunotherapy agents and approaches to ensure access and adherence to newly approved immunotherapy-based treatments, appropriate supportive care measures, and support for financial issues related to patients’ treatment.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.